EcoDrugPlus

Solute Carrier Family 6 Member 3

Ensembl ID : ENSBBBG00000016720
Gene Symbol: SLC6A3
3 Cross references
166 Possible Orthologues:

Solute Carrier Family 6 Member 4

Ensembl ID : ENSBBBG00000000694
Gene Symbol: SLC6A4
3 Cross references
205 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSBBBG00000001699
Gene Symbol: SLC6A9
2 Cross references
200 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSBBBG00000017032
Gene Symbol: SLC9A3
3 Cross references
238 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSBBBG00000025468
Gene Symbol: SSTR1
1 Cross references
160 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSBBBG00000023240
Gene Symbol: SSTR2
3 Cross references
264 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSBBBG00000005029
Gene Symbol: SSTR3
3 Cross references
251 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSBBBG00000019675
Gene Symbol: SSTR5
1 Cross references
257 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSBBBG00000007296
Gene Symbol: S1PR1
3 Cross references
194 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSBBBG00000011990
Gene Symbol: SYK
3 Cross references
203 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSBBBG00000018622
Gene Symbol: SRD5A2
3 Cross references
266 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSBBBG00000013899
Gene Symbol: SOAT1
3 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).